Comparative of in-vitro Evaluation between Erlotinib Loaded Nanostructured Lipid Carriers and Liposomes against A549 Lung Cancer Cell Line.

Autor: Gaballu, Fereydoon Abedi^1,2,3, Abbaspour-Ravasjani, Soheil³, Mansoori, Behzad¹, Yekta, Reza³, Hamishehkar, Hamed⁴, Mohammadi, Ali, Dehghan, Gholamreza, Shokouhi, Behrooz⁵, Dehbokri, Shaho Ghahremani¹ ghahremanish@tbzmed.ac.ir, Baradaran, Behzad¹ baradaranb@tbzmed.ac.ir

Publikováno v: Iranian Journal of Pharmaceutical Research. Spring2019, Vol. 18 Issue 3, p1168-1179. 12p.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

miR-330 Regulates Colorectal Cancer Oncogenesis by Targeting BACH1

Autor: Behzad Baradaran, Neda Shajari, Behzad Mansoori, Ali Mohammadi, Katayoon Nofouzi, Pascal H.G. Duijf, Fereydoon Abedi Gaballu, Solmaz Shirjang, Souzan Najafi

Publikováno v: Advanced Pharmaceutical Bulletin, Vol 10, Iss 3, Pp 444-451 (2020)
Advanced Pharmaceutical Bulletin
Shirjang, S, Mansoori, B, Mohammad, A, Shajari, N, Duijf, P H G, Najaf, S, Gaballu, F A, Nofouzi, K & Baradaran, B 2020, ' miR-330 Regulates Colorectal Cancer Oncogenesis by Targeting BACH1 ', Advanced pharmaceutical bulletin, vol. 10, no. 3, pp. 444-451 . https://doi.org/10.34172/apb.2020.054

Purpose: Based on WHO report, colorectal cancer (CRC) is the second cause of death among patients with cancer worldwide. Dysregulation of miRNAs expressions has been demonstrated in different human cancers, especially CRC. Studies have shown that miR

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e6fba93f8a278a61e95e484c6d2e0b7
https://apb.tbzmed.ac.ir/PDF/apb-28119